Nazanin Majd

7PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

|Jun 14, 2026
Cystic glioblastoma is associated with alterations of KDR and the Rb pathway: a single-center retrospective analysis.

|Jul 11, 2024
Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature.

Cindy M Pabon, Debra N Yeboa, Barbara J O'Brien

|Jun 05, 2024
Metastatic extraneural glioblastoma diagnosed with molecular testing.

Nazanin K Majd, Henry Hiep Vo, Cesar A Moran

|May 30, 2024
Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.

Lily C Pham, Lauryn Weller, Claudia N Gann

|Feb 23, 2024
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes.

Keng Lam, Carlos Kamiya-Matsuoka, John M Slopis

Pageof 2

Frequent Collaborators

1 joint publications

Keng Lam

1 joint publications

John M Slopis

1 joint publications

Lauryn Weller

1 joint publications

Henry Hiep Vo